Atlas Trials

Schizoaffective Disorders

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Schizoaffective Disorders

RecordFirmDate
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients (NCT02307396)Technical University of Munich2015-02-01
Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor) (NCT01729650)Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina2012-06-01
A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder (NCT01389908)Shalvata Mental Health Center2011-06-01
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia (NCT01082588)Massachusetts General Hospital2010-06-01
Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia (NCT00847600)Sha'ar Menashe Mental Health Center2009-03-01
An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment (NCT00526877)Johnson & Johnson Taiwan Ltd2007-07-13
Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder (NCT00457899)AstraZeneca2007-07-01
Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine (NCT00401973)Eli Lilly and Company2006-11-01
Supervised Treatment of Schizophrenia, a Randomized Controlled Trial. (NCT00392249)Lady Reading Hospital, Pakistan2006-11-01
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) (NCT00453804)State University of New York - Upstate Medical University2006-07-01
Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects (NCT00328978)AstraZeneca2003-10-01
Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet. (NCT00645502)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2003-06-01
A Comparative Study of New Medications for Psychosis in Adolescents (NCT00222495)University of Minnesota2002-08-01

Track Schizoaffective Disorders automatically

Every clearance here is in the API, with alerts when new ones post.